Abbott, the global healthcare leader, has announced new collaborations with key health-tech partners BeatO, Sugar.fit, PharmEasy, GOQii, 1MG, Zyla Health, Healthifyme and Fitterfly to usher a new era of holistic diabetes management care.
Through these collaborations, Abbott aims to offer glucose monitoring solutions to 8 million people living with diabetes, of which approximately 6.5mn users can access through PharmEasy and 1MG.
Abbott has also partnered with BeatO, a digital health platform to launch a holistic, data-based continuous glucose monitoring program for better diabetes management. The program provides users access to targeted diet, help in controlling diabetes and lifestyle counselling from experts based on the data recorded by FreeStyle Libre. Kalyan Sattaru, General Manager of the diabetes care business at Abbott, said, “New diabetes technology has paved the way for precise and informed decision making. Connecting our partner brands’ products with the FreeStyle Libre portfolio will enable users to capture their glucose data easily as part of an integrated system.”
